Publications en collaboration avec des chercheurs de Universidad de Salamanca (1)

2020

  1. Opipramol inhibits lipolysis in human adipocytes without altering glucose uptake and differently from antipsychotic and antidepressant drugs with adverse effects on body weight control

    Pharmaceuticals, Vol. 13, Núm. 3